Skip to content
HowShorted

Atara Biotherapeutics, Inc. short interest in 2026

In 2026, Atara Biotherapeutics, Inc.'s disclosed short interest ran from 3.92% of shares outstanding on 30 Jan 2026 to 4.03% on 15 Sep 2026, a change of +0.11 percentage points. The year's high was 7.06% on 15 Jul 2026 and its low 2.90% on 13 Feb 2026, averaging 4.79% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.07 days on 31 Aug 2026. Full history: Atara Biotherapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Atara Biotherapeutics, Inc. in 2026

2026 in figures

Start of year
3.92% (30 Jan 2026)
End of year
4.03% (15 Sep 2026)
Change
+0.11 pp
High
7.06% (15 Jul 2026)
Low
2.90% (13 Feb 2026)
Average
4.79%
Highest days to cover
11.07 (31 Aug 2026)
SEC filings marked
6

Every report in 2026

Atara Biotherapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
30 Jan 20263.92%1.00results (8-K)
13 Feb 20262.90%2.40
27 Feb 20264.58%2.13
13 Mar 20263.83%1.00
31 Mar 20264.00%3.0110-K filed, results (8-K)
15 Apr 20263.89%4.10
30 Apr 20263.74%6.10
15 May 20266.68%1.0010-Q filed
29 May 20265.92%2.91
15 Jun 20266.02%6.27
30 Jun 20264.42%3.95
15 Jul 20267.06%6.24
31 Jul 20266.57%9.39
14 Aug 20264.75%9.2110-Q filed, results (8-K)
31 Aug 20264.26%11.07
15 Sep 20264.03%7.34

See also: Atara Biotherapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.